
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6442825
[patent_doc_number] => 20100144540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'CORRELATION OF MOLECULAR MARKERS WITH CLINICAL OUTCOME IN GBM PATIENTS RADIATION TREATED WITH OR WITHOUT GEFITINIB'
[patent_app_type] => utility
[patent_app_number] => 12/564698
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8101
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144540.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564698
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564698 | Correlation of molecular markers with clinical outcome in GBM patients radiation treated with or without gefitinib | Sep 21, 2009 | Issued |
Array
(
[id] => 6187820
[patent_doc_number] => 20110171219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/119426
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25611
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171219.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119426
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119426 | TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS | Sep 20, 2009 | Abandoned |
Array
(
[id] => 8920462
[patent_doc_number] => 08486393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma'
[patent_app_type] => utility
[patent_app_number] => 13/119428
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 27560
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119428
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119428 | Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma | Sep 17, 2009 | Issued |
Array
(
[id] => 4433917
[patent_doc_number] => 07897741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-01
[patent_title] => 'Cell cycle phase markers'
[patent_app_type] => utility
[patent_app_number] => 12/560519
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 12936
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/897/07897741.pdf
[firstpage_image] =>[orig_patent_app_number] => 12560519
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/560519 | Cell cycle phase markers | Sep 15, 2009 | Issued |
Array
(
[id] => 6585180
[patent_doc_number] => 20100047847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Methods for diagnosing ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 12/584832
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16412
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047847.pdf
[firstpage_image] =>[orig_patent_app_number] => 12584832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/584832 | Methods for diagnosing ovarian cancer | Sep 10, 2009 | Issued |
Array
(
[id] => 6371177
[patent_doc_number] => 20100075325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/557795
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44111
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075325.pdf
[firstpage_image] =>[orig_patent_app_number] => 12557795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557795 | COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER | Sep 10, 2009 | Abandoned |
Array
(
[id] => 6304440
[patent_doc_number] => 20100068736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/557253
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 123
[patent_no_of_words] => 331211
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068736.pdf
[firstpage_image] =>[orig_patent_app_number] => 12557253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557253 | Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer | Sep 9, 2009 | Abandoned |
Array
(
[id] => 6163513
[patent_doc_number] => 20110160293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'PRMT1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/060672
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25646
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160293.pdf
[firstpage_image] =>[orig_patent_app_number] => 13060672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060672 | PRMT1 for target genes of cancer therapy and diagnosis | Aug 24, 2009 | Issued |
Array
(
[id] => 6110306
[patent_doc_number] => 20110189186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'AFFECTING BONE RELATED CONDITIONS USING CD68 BLOCKING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/061471
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8795
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189186.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061471
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061471 | AFFECTING BONE RELATED CONDITIONS USING CD68 BLOCKING AGENTS | Aug 16, 2009 | Abandoned |
Array
(
[id] => 10082469
[patent_doc_number] => 09119800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'HIG2 and URLC10 epitope peptide and vaccines containing the same'
[patent_app_type] => utility
[patent_app_number] => 13/059618
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 13277
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059618 | HIG2 and URLC10 epitope peptide and vaccines containing the same | Aug 13, 2009 | Issued |
Array
(
[id] => 6062164
[patent_doc_number] => 20110200597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'SIGNAL PATHWAY ALTERATIONS AND DRUG TARGET ELEVATIONS IN PRIMARY METACHRONOUS METASTATIC COLORECTAL CANCER COMPARED TO NON-METASTATIC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/057409
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7546
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20110200597.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057409
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057409 | SIGNAL PATHWAY ALTERATIONS AND DRUG TARGET ELEVATIONS IN PRIMARY METACHRONOUS METASTATIC COLORECTAL CANCER COMPARED TO NON-METASTATIC DISEASE | Aug 4, 2009 | Abandoned |
Array
(
[id] => 6491617
[patent_doc_number] => 20100093556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/512655
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 100809
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12512655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/512655 | Compositions and methods for treating and diagnosing cancer | Jul 29, 2009 | Issued |
Array
(
[id] => 7733202
[patent_doc_number] => 20120015835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles'
[patent_app_type] => utility
[patent_app_number] => 12/511028
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 80
[patent_no_of_words] => 28623
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015835.pdf
[firstpage_image] =>[orig_patent_app_number] => 12511028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/511028 | Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles | Jul 27, 2009 | Abandoned |
Array
(
[id] => 6143134
[patent_doc_number] => 20110129849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'DETECTION OF PROSTATE CANCER USING PSA GLYCOSYLATION PATTERNS'
[patent_app_type] => utility
[patent_app_number] => 13/055868
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16587
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129849.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055868 | DETECTION OF PROSTATE CANCER USING PSA GLYCOSYLATION PATTERNS | Jul 26, 2009 | Abandoned |
Array
(
[id] => 7504209
[patent_doc_number] => 20110265197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/054468
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 35034
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20110265197.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054468
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054468 | Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof | Jul 15, 2009 | Abandoned |
Array
(
[id] => 9285948
[patent_doc_number] => 08642274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Immunotherapeutic method'
[patent_app_type] => utility
[patent_app_number] => 12/503512
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 22585
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12503512
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/503512 | Immunotherapeutic method | Jul 14, 2009 | Issued |
Array
(
[id] => 6102081
[patent_doc_number] => 20110165573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'METHOD TO DETECT PROSTATE CANCER IN A SAMPLE'
[patent_app_type] => utility
[patent_app_number] => 12/500749
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16704
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500749
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500749 | Method to detect prostate cancer in a sample | Jul 9, 2009 | Issued |
Array
(
[id] => 7656774
[patent_doc_number] => 20110306043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/500541
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 84
[patent_figures_cnt] => 84
[patent_no_of_words] => 44875
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500541 | DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES | Jul 8, 2009 | Abandoned |
Array
(
[id] => 7534803
[patent_doc_number] => 08048425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Cytotoxic ribonuclease variants'
[patent_app_type] => utility
[patent_app_number] => 12/497038
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13843
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048425.pdf
[firstpage_image] =>[orig_patent_app_number] => 12497038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/497038 | Cytotoxic ribonuclease variants | Jul 1, 2009 | Issued |
Array
(
[id] => 6187747
[patent_doc_number] => 20110171191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'SUPPRESSION OF NEUROENDOCRINE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/996643
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 46986
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996643 | SUPPRESSION OF NEUROENDOCRINE DISEASES | Jun 10, 2009 | Abandoned |